Your browser doesn't support javascript.
loading
YKL-40 derived from infiltrating macrophages cooperates with GDF15 to establish an immune suppressive microenvironment in gallbladder cancer.
Wang, Ziyi; Wang, Shijia; Jia, Ziheng; Hu, Yunping; Cao, Dongyan; Yang, Mingjie; Liu, Liguo; Gao, Li; Qiu, Shimei; Yan, Weikang; Li, Yiming; Luo, Jing; Geng, Yajun; Zhang, Jingyun; Li, Zhizhen; Wang, Xuan; Li, Maolan; Shao, Rong; Liu, Yingbin.
Afiliación
  • Wang Z; Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Cancer Institute, State Key Laboratory of Oncogenes and Related Genes, Shanghai, China.
  • Wang S; Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Cancer Institute, State Key Laboratory of Oncogenes and Related Genes, Shanghai, China.
  • Jia Z; Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Cancer Institute, State Key Laboratory of Oncogenes and Related Genes, Shanghai, China.
  • Hu Y; Institute of Pathology and Southwest Cancer Center, The First Affiliated Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Cao D; Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Cancer Institute, State Key Laboratory of Oncogenes and Related Genes, Shanghai, China.
  • Yang M; Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Cancer Institute, State Key Laboratory of Oncogenes and Related Genes, Shanghai, China.
  • Liu L; Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Cancer Institute, State Key Laboratory of Oncogenes and Related Genes, Shanghai, China.
  • Gao L; CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
  • Qiu S; Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Cancer Institute, State Key Laboratory of Oncogenes and Related Genes, Shanghai, China.
  • Yan W; Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Cancer Institute, State Key Laboratory of Oncogenes and Related Genes, Shanghai, China.
  • Li Y; Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Cancer Institute, State Key Laboratory of Oncogenes and Related Genes, Shanghai, China.
  • Luo J; Department of Biliary Tract Surgery I, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
  • Geng Y; Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Cancer Institute, State Key Laboratory of Oncogenes and Related Genes, Shanghai, China.
  • Zhang J; Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Cancer Institute, State Key Laboratory of Oncogenes and Related Genes, Shanghai, China.
  • Li Z; Department of Pharmacology and Biochemistry, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang X; Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Li M; Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: limaolan6@163.com.
  • Shao R; Shanghai Cancer Institute, State Key Laboratory of Oncogenes and Related Genes, Shanghai, China; Department of Pharmacology and Biochemistry, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai key lab for gallbladder - related gastroenterological diseases, Xinhua hospital Af
  • Liu Y; Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Cancer Institute, State Key Laboratory of Oncogenes and Related Genes, Shanghai, China. Electronic address: laoniulyb@shsmu.edu.cn.
Cancer Lett ; 563: 216184, 2023 06 01.
Article en En | MEDLINE | ID: mdl-37088328
ABSTRACT
Despite of the high lethality of gallbladder cancer (GBC), little is known regarding molecular regulation of the tumor immunosuppressive microenvironment. Here, we determined tumor expression levels of YKL-40 and the molecular mechanisms by which YKL-40 regulates escape of anti-tumor immune surveillance. We found that elevated expression levels of YKL-40 in plasma and tissue were correlated with tumor size, stage IV and lymph node metastasis. Single cell transcriptome analysis revealed that YKL-40 was predominantly derived from M2-like subtype of infiltrating macrophages. Blockade of M2-like macrophage differentiation of THP-1 cells with YKL-40 shRNA resulted in reprogramming to M1-like macrophages and restricting tumor development. YKL-40 induced tumor cell expression and secretion of growth differentiation factor 15 (GDF15), thus coordinating to promote PD-L1 expression mediated by PI3K, AKT and/or Erk activation. Interestingly, extracellular GDF15 inhibited intracellular expression of GDF15 that suppressed PD-L1 expression. Thus, YKL-40 disrupted the balance of pro- and anti-PD-L1 regulation to enhance expression of PD-L1 and inhibition of T cell cytotoxicity, leading to tumor immune evasion. The data suggest that YKL-40 and GDF15 could serve as diagnostic biomarkers and immunotherapeutic targets for GBC.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vesícula Biliar Límite: Humans Idioma: En Revista: Cancer Lett Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vesícula Biliar Límite: Humans Idioma: En Revista: Cancer Lett Año: 2023 Tipo del documento: Article País de afiliación: China